| scholarly article | Q13442814 |
| P356 | DOI | 10.1021/JS970034D |
| P698 | PubMed publication ID | 9294813 |
| P2093 | author name string | Manning MC | |
| Carpenter JF | |||
| Dong A | |||
| Stratton LP | |||
| P2860 | cites work | Counteracting effects of thiocyanate and sucrose on chymotrypsinogen secondary structure and aggregation during freezing, drying, and rehydration | Q30425642 |
| Stability of protein pharmaceuticals | Q38734028 | ||
| Infrared methods for study of hemoglobin reactions and structures | Q40687237 | ||
| Characterization by infrared spectroscopy of the bilayer to nonbilayer phase transition of phosphatidylethanolamines | Q41630823 | ||
| A sensitive new substrate for chymotrypsin | Q44163410 | ||
| Lipid phase transitions measured in intact cells with Fourier transform infrared spectroscopy. | Q45995799 | ||
| Biological activity of urease formulated in poloxamer 407 after intraperitoneal injection in the rat | Q67559217 | ||
| Sustained delivery of interleukin-2 from a poloxamer 407 gel matrix following intraperitoneal injection in mice | Q68177118 | ||
| Polymers protect lactate dehydrogenase during freeze-drying by inhibiting dissociation in the frozen state | Q71530728 | ||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | drug delivery | Q1392806 |
| P304 | page(s) | 1006-1010 | |
| P577 | publication date | 1997-09-01 | |
| P1433 | published in | Journal of Pharmaceutical Sciences | Q3186933 |
| P1476 | title | Drug delivery matrix containing native protein precipitates suspended in a poloxamer gel | |
| P478 | volume | 86 |
| Q36649745 | A review of poloxamer 407 pharmaceutical and pharmacological characteristics. |
| Q77182872 | Aggregation of recombinant human interferon gamma: kinetics and structural transitions |
| Q77398433 | Cloud point of nonionic surfactants: modulation with pharmaceutical excipients |
| Q34183401 | Delivery of Flt3 ligand (Flt3L) using a poloxamer-based formulation increases biological activity in mice. |
| Q37360808 | Development of tetracycline-serratiopeptidase-containing periodontal gel: formulation and preliminary clinical study |
| Q73215834 | Dose-dependent hyperlipidemia in rabbits following administration of poloxamer 407 gel |
| Q74533503 | Effects of additives on the stability of Humicola lanuginosa lipase during freeze-drying and storage in the dried solid |
| Q28539911 | Evaluation of an injectable thermosensitive hydrogel as drug delivery implant for ocular glaucoma surgery |
| Q38116457 | IL-1Ra and its delivery strategies: inserting the association in perspective. |
| Q37360916 | In vitro and in vivo evaluation of topical formulations of spantide II. |
| Q63347521 | New Insight into the Role of Polyethylene Glycol Acting as Protein Release Modifier in Lipidic Implants |
| Q31876181 | Pluronic F-127 gels incorporating highly purified unsaturated fatty acids for buccal delivery of insulin |
| Q33203706 | Pluronic F127-based systemic vaccine delivery systems |
| Q91964521 | Poloxamer Hydrogels for Biomedical Applications |
| Q37310864 | Self-assembling materials for therapeutic delivery |
| Q37689616 | Stability of protein pharmaceuticals: an update |
| Q34586474 | Sustained delivery of IL-1Ra from PF127-gel reduces hyperglycemia in diabetic GK-rats |
| Q84830552 | Sustained delivery of IL-1Ra from pluronic F127-based thermosensitive gel prolongs its therapeutic potentials |
| Q44479967 | Thermal and photochemical nitric oxide release from S-nitrosothiols incorporated in Pluronic F127 gel: potential uses for local and controlled nitric oxide release. |
| Q41563319 | Thermogelling properties of purified poloxamer 407. |
Search more.